August 23, 2024 10:29 AM EDTUpdated 10:43 AM
News Briefing

Novo's in­no­va­tion hub ex­pands to Bay Area; SIGA's new Tpoxx or­der

Kyle LaHucik

Senior Reporter

No­vo Nordisk’s Bio In­no­va­tion Hub goes west: The Dan­ish phar­ma’s ear­ly-stage R&D unit is part­ner­ing with MBC Bi­o­Labs, an in­cu­ba­tor in …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
ENDPOINTS CAREERS

Sr. Manager/Associate Director, Document Control

Viridian Therapeutics

Waltham, MA, USA

TRENDING NOW

Charles Riv­er to lay off 3% of staffers as it stream­lines spend­ing

Mod­er­na plans $1.1B in R&D and pro­gram cuts, de­lays break-even point to 2028

Sofinno­va’s Jim Healy on ‘more ra­tio­nal mar­ket’ as four biotech star­tups near their IPOs

Seres' mi­cro­bio­me ther­a­py re­duces in­fec­tions in stem cell trans­plant pa­tients, but next steps are un­clear

Lil­ly bud­gets $1.8B to boost Kisun­la, GLP-1 man­u­fac­tur­ing in Ire­land

Noom of­fers com­pound­ed GLP-1 drugs, promis­es pa­tients can quit and keep weight off

A service from the Financial Times